The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
FGF23 signaling impairs neutrophil recruitment and host defense during CKD
Open accessAbstract
Chronic kidney disease (CKD) has been associated with impaired host response and increased susceptibility to infections. Leukocyte recruitment during inflammation must be tightly regulated to protect the host against pathogens. FGF23 levels are increased in blood during CKD, and levels of this hormone have been associated with a variety of adverse effects in CKD patients. Here, we have shown that CKD impairs leukocyte recruitment into inflamed tissue and host defense in mice and humans. FGF23 neutralization during CKD in murine models restored leukocyte recruitment and host defense. Intravital microscopy of animals with chronic kidney failure showed that FGF23 inhibits chemokine-activated leukocyte arrest on the endothelium, and downregulation of FGF receptor 2 (FGFR2) on PMNs rescued host defense in these mice. In vitro, FGF23 inhibited PMN adhesion, arrest under flow, and transendothelial migration. Mechanistically, FGF23 binding to FGFR2 counteracted selectin- and chemokine-triggered β2 integrin activation on PMNs by activating protein kinase A (PKA) and inhibiting activation of the small GTPase Rap1. Moreover, knockdown of PKA abolished the inhibitory effect of FGF23 on integrin activation. Together, our data reveal that FGF23 acts directly on PMNs and dampens host defense by direct interference with chemokine signaling and integrin activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationCellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,929
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Structural Basis of Integrin Regulation and Signaling
Luo, B.-H., Carman, C. V., & Springer, T. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141618 · Cited by 1,660
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
The neutrophil in vascular inflammation
Phillipson, M., & Kubes, P. (2011) · Nature Medicine · doi:10.1038/nm.2514 · Cited by 768
Cause of Death in Patients with Reduced Kidney Function
Thompson, S., James, M., Wiebe, N., Hemmelgarn, B., Manns, B., Klarenbach, S., & Tonelli, M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070714 · Cited by 658
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Grabner, A., Amaral, A. P., Schramm, K., Singh, S., Sloan, A., Yanucil, C., Li, J., Shehadeh, L. A., Hare, J. M., David, V., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.002 · Cited by 541
Self-citationKempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Rossaint, J., Bolomini-Vittori, M., Korf-Klingebiel, M., Napp, L. C., Hansen, B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2354 · Cited by 518 · cited 9×
“After lysis with ice-cold lysis buffer (50 mm TrisHCl [pH 7.4]; 500 mM NaCl; 1% NP40; 10% glycerol; 2.5 mM MgCl 2 ; 10 μ g/ml PEFA-Block; 25 mM NaF; 1 mM vanadate; and 1 mM PMSF [1% Roche HALT protease inhibitor cocktail]), GTP-bound Rap1 (Rap1-GTP) was precipitated from whole cell lysates using GST-Ral beads”
InfluentialLavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J., & Naveh-Many, T. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00360.2010 · Cited by 441
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss
Eskan, M. A., Jotwani, R., Abe, T., Chmelar, J., Lim, J.-H., Liang, S., Ciero, P. A., Krauss, J. L., Li, F., Rauner, M., et al. (2012) · Nature Immunology · doi:10.1038/ni.2260 · Cited by 429
Shalhoub, V., Shatzen, E. M., Ward, S. C., Davis, J., Stevens, J., Bi, V., Renshaw, L., Hawkins, N., Wang, W., Chen, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61405 · Cited by 413
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Mócsai, A., Abram, C. L., Jakus, Z., Hu, Y., Lanier, L. L., & Lowell, C. A. (2006) · Nature Immunology · doi:10.1038/ni1407 · Cited by 368
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
Vaziri, N. D. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.06.026 · Cited by 355
Zarbock, A., Lowell, C. A., & Ley, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.011 · Cited by 292
Self-citationRecio-Mayoral, A., Banerjee, D., Streather, C., & Kaski, J. C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.017 · Cited by 236
Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling-Perry, K., Wolf, M., Salusky, I. B., & Jüppner, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1603 · Cited by 229
Zarbock, A., Abram, C. L., Hundt, M., Altman, A., Lowell, C. A., & Ley, K. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072660 · Cited by 198
Self-citationBacchetta, J., Sea, J. L., Chun, R. F., Lisse, T. S., Wesseling-Perry, K., Gales, B., Adams, J. S., Salusky, I. B., & Hewison, M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1740 · Cited by 189
Kuwano, Y., Spelten, O., Zhang, H., Ley, K., & Zarbock, A. (2010) · Blood · doi:10.1182/blood-2010-01-266122 · Cited by 170
Self-citationMueller, H., Stadtmann, A., Van Aken, H., Hirsch, E., Wang, D., Ley, K., & Zarbock, A. (2010) · Blood · doi:10.1182/blood-2009-11-254185 · Cited by 164
Self-citationSchnoor, M., Lai, F. P. L., Zarbock, A., Kläver, R., Polaschegg, C., Schulte, D., Weich, H. A., Oelkers, J. M., Rottner, K., & Vestweber, D. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101920 · Cited by 159
Self-citationLeelahavanichkul, A., Huang, Y., Hu, X., Zhou, H., Tsuji, T., Chen, R., Kopp, J. B., Schnermann, J., Yuen, P. S. T., & Star, R. A. (2011) · Kidney International · doi:10.1038/ki.2011.261 · Cited by 158
Annexin A1 Counteracts Chemokine-Induced Arterial Myeloid Cell Recruitment
Drechsler, M., de Jong, R., Rossaint, J., Viola, J. R., Leoni, G., Wang, J. M., Grommes, J., Hinkel, R., Kupatt, C., Weber, C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.305825 · Cited by 150
Self-citationChonchol, M., Greene, T., Zhang, Y., Hoofnagle, A. N., & Cheung, A. K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101009 · Cited by 148
Kinashi, T., Aker, M., Sokolovsky-Eisenberg, M., Grabovsky, V., Tanaka, C., Shamri, R., Feigelson, S. W., Etzioni, A., & Alon, R. (2003) · Blood · doi:10.1182/blood-2003-07-2499 · Cited by 112
Yu, H., Hsieh, P., Chang, Y.-J., Chung, P.-J., Kuo, L.-M., & Hwang, T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.026 · Cited by 109
The PSGL-1–L-selectin signaling complex regulates neutrophil adhesion under flow
Stadtmann, A., Germena, G., Block, H., Boras, M., Rossaint, J., Sundd, P., Lefort, C. T., Fisher, C. I., Buscher, K., Gelschefarth, B., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130664 · Cited by 108
Self-citationIttner, A., Block, H., Reichel, C. A., Varjosalo, M. T., Gehart, H., Sumara, G., Gstaiger, M., Krombach, F., Zarbock, A., & Ricci, R. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120677 · Cited by 106
Self-citationLey, K. F. (2003) · Microcirculation · doi:10.1038/sj.mn.7800194 · Cited by 104
Block, H., Herter, J. M., Rossaint, J., Stadtmann, A., Kliche, S., Lowell, C. A., & Zarbock, A. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111493 · Cited by 103
Self-citationKinashi, T., & Katagiri, K. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.02.008 · Cited by 99
Gαi2 is required for chemokine-induced neutrophil arrest
Zarbock, A., Deem, T. L., Burcin, T. L., & Ley, K. F. (2007) · Blood · doi:10.1182/blood-2007-06-094565 · Cited by 95
Self-citationMizuno, R., Kamioka, Y., Kabashima, K., Imajo, M., Sumiyama, K., Nakasho, E., Ito, T., Hamazaki, Y., Okuchi, Y., Sakai, Y., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132112 · Cited by 95
Stadtmann, A., Brinkhaus, L., Mueller, H., Rossaint, J., Bolomini‐Vittori, M., Bergmeier, W., Aken, H. V., Wagner, D. D., Laudanna, C., Ley, K. F., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041196 · Cited by 94
Self-citationHerter, J. M., Rossaint, J., Block, H., Welch, H. C. E., & Zarbock, A. (2013) · Blood · doi:10.1182/blood-2012-09-457085 · Cited by 69
Self-citationGDF‐15 prevents platelet integrin activation and thrombus formation
Rossaint, J., Vestweber, D., & Zarbock, A. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12100 · Cited by 66
Self-citationVASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis
Neel, N. F., Barzik, M., Raman, D., Sobolik-Delmaire, T., Sai, J., Ham, A. L., Mernaugh, R. L., Gertler, F. B., & Richmond, A. J. (2009) · Journal of Cell Science · doi:10.1242/jcs.039057 · Cited by 65
Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation
Zarbock, A., Kempf, T., Wollert, K. C., & Vestweber, D. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0835-2 · Cited by 63
Self-citationCardiac Myocyte-Derived Follistatin-Like 1 Prevents Renal Injury in a Subtotal Nephrectomy Model
Hayakawa, S., Ohashi, K., Shibata, R., Kataoka, Y., Miyabe, M., Enomoto, T., Joki, Y., Shimizu, Y., Kambara, T., Uemura, Y., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014020210 · Cited by 59
Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals
Isakova, T., Cai, X., Lee, J. J., Katz, R., Cauley, J. A., Fried, L. F., Hoofnagle, A. N., Satterfield, S., Harris, T. B., Shlipak, M. G., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2750 · Cited by 59
Rossaint, J., Spelten, O., Kässens, N., Mueller, H., Aken, H. K. V., Singbartl, K., & Zarbock, A. (2011) · Kidney International · doi:10.1038/ki.2011.125 · Cited by 58
Self-citationWeinman, E. J., Steplock, D., Shenolikar, S., & Biswas, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288357 · Cited by 54
Haddad, L. E., Khzam, L. B., Hajjar, F., Merhi, Y., & Sirois, M. G. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00215.2011 · Cited by 40
Uremia Suppresses Immune Signal-Induced CYP27B1 Expression in Human Monocytes
Viaene, L., Evenepoel, P., Meijers, B. K. I., Vanderschueren, D., Overbergh, L., & Mathieu, C. (2012) · American Journal of Nephrology · doi:10.1159/000345146 · Cited by 37
Li, J., Zhao, L., Xie, H., Zeng, Y., & Dai, S.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059257 · Cited by 34
Germena, G., Volmering, S., Sohlbach, C., & Zarbock, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401646 · Cited by 27
Self-citationThe AGC Kinase Inhibitor H89 Attenuates Airway Inflammation in Mouse Models of Asthma
Reber, L. L., Daubeuf, F., Nemska, S., & Frossard, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049512 · Cited by 24
Cited by
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Beck-Nielsen, S. S., Mughal, Z., Haffner, D., Nilsson, O., Levtchenko, E., Ariceta, G., de Lucas Collantes, C., Schnabel, D., Jandhyala, R., & Mäkitie, O. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1014-8 · Cited by 278
FGF23 signalling and physiology
Ho, B. B., & Bergwitz, C. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0178 · Cited by 180
Metadata
- Authors
- Rossaint, J., Oehmichen, J., Van Aken, H., Reuter, S., Pavenstädt, H. J., Meersch, M., Unruh, M., & Zarbock, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-02-15
- Volume
- 126
- Issue
- 3
- Pages
- 962-974
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2274689835
- Cited by
- 276
- References
- 58
- FWCI
- 32.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.